Vincent A. Forlenza is President and Chief Executive Officer of BD (Becton, Dickinson and Company), a leading global medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents. As President of Becton, Dickinson and Company Forlenza oversees the firm's three business segments (BD Medical, BD Diagnostics and BD Biosciences), as well as the firm's International and Quality functions.
Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs approximately 28,000 people in approximately 50 countries throughout the world. The company serves healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public.
Prior to this appointment, Forlenza served as President of BD's Biosciences Division since March 2003. He joined BD in 1980 and spent the next several years in various positions of increasing responsibility in the United States and Europe in strategic planning, business development and general management of several business units. In 1996, Forlenza was appointed president of Becton Dickinson Microbiology Systems in Sparks, Maryland, and assumed the position of Senior Vice President, Technology, Strategy and Development in October 1998. Forlenza has been involved in various professional and community associations. He currently serves as vice chairman of The Valley Hospital board of trustees.
He is also a member of Lehigh University's Board of Trustees and is a former member of Lehigh's Engineering Advisory Council.
Forlenza obtained his bachelor's degree in chemical engineering from Lehigh University in 1975 and his master's of business administration from Wharton Graduate School, University of Pennsylvania, in 1980.